Corvus Pharmaceuticals(CRVS) - 2023 Q2 - Quarterly Report

FORM 10-Q ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Emerging growth company ☐ TABLE OF CONTENTS | --- | --- | |----------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...